USPTO serial 75904220
ADRANDOM
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- SNAPP, TINA LOUISE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ADRANDOM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CORI ANSCHER
CORI ANSCHER FISH AND NEAVE1251 AVE OF THE AMERICAS FL 50NEW YORK, NY 10020-1105UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Genetic modified cell and cell lines, viruses, polynucleic acids, polynucleotides, proteins, polypeptides and biochemicals all for use in the manufacture of pharmaceuticals and for scientific and laboratory research | ACTIVE | — |
| 005 | Genetic modified cell and cell lines, viruses, polynucleic acids, polynucleotides, proteins, polypeptides and biochemicals all for medical and clinical use | ACTIVE | — |
| 040 | Treatment of cells and cell lines, viruses, polynucleic acids, polynucleotides, proteins, polypeptides and biochemicals for use in the manufacture of pharmaceuticals or genetic modified biochemicals | ACTIVE | — |
| 042 | Scientific research; services in the medical and biochemical field, especially the examination and testing of genes, development, examination and testing of pharmaceutical and biochemical semi-finished products especially for use in medicines, the development, examination and testing of medicines, the development of test systems for genetically modified material for the preparation of pharmaceutical products and for research and diagnostic purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Galapagos Genomics N.V.
- Other trademarks owned by Galapagos Genomics N.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named ADRANDOM
- Prosecution event ABN6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 13, 2003 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 26, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 1, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 12, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 26, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2001 | 44DD | SEC. 44(D) CLAIM DELETED | — |
| Jul 19, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 1, 2001 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Jun 22, 2000 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jun 16, 2000 | DOCK | ASSIGNED TO EXAMINER | — |